Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry

Biomedical Chromatography

Volumn 20, Issue 11, 2006, Pages 1229-1236

  Cho, Sung Hee ^a,b   Jung, Byung Hwa ^a   Lee, Sang Hee ^a   Lee, Won Yong ^b   Kong, Gu ^c   Chung, Bong Chul ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Breast cancer; Column switching liquid chromatography; Mass spectrometry; Nucleosides; Urine

Indexed keywords

BIOMOLECULES; BODY FLUIDS; COLUMN CHROMATOGRAPHY; DISEASES; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; SIGNAL TO NOISE RATIO;

ANALYTICAL METHOD; BREAST CANCER; COLUMN SWITCHING; COLUMN-SWITCHING LIQUID CHROMATOGRAPHY; DIRECT DETERMINATION; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; NUCLEOSIDE; SIMPLE++; URINE;

MASS SPECTROMETRY;

1 METHYLADENOSINE; 5 HYDROXYMETHYLDEOXYURIDINE; 8 HYDROXYDEOXYGUANOSINE; N2,N2 DIMETHYLGUANOSINE; NUCLEOSIDE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; BREAST CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY;

EID: 33751075451     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.689     Document Type: Article

References (25)

1. Abe T, Isobe C, Murata T, Sato C and Tohgi H. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease. Neuroscience Letters 2003; 336: 105.
2. Abe T, Tohgi H, Isobe C, Murata T and Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. Journal of Neuroscience Research 2002; 70: 447.
3. Bershtein LM, Levina VV, Poroshina TE and Tsyrlina EV. Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. Bulletin of Experimental Biology and Medicine 2005; 140: 88.
4. Borek E and Kerr SJ. Biological tRNAs and their orgin in tumor tissue. Advances in Cancer Research 1972; 15: 163.
5. Borek E, Sharma OK and Waalkes TP. New applications of urinary nucleoside markers. Recent Results in Cancer Research 1983; 84: 301.
6. Djuric Z, Heilbrun LK, Lababidi S, Berzinkas E, Simon MS and Kosir MA. Levels of 5-hydroxymethyl-2′-deoxyuridine in DNA from blood of women scheduled for breast biopsy. Cancer Epidemiology, Biomarkers and Prevention 2001; 10: 147.
7. Dudley E, El-Sharkawi S, Games DE and Newton RP. Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/ electrospray mass spectrometr. Rapid Communications in Mass Spectrometry 2000; 14: 1200.
8. Evans MD, Cooke MS, Podmore ID, Zheng Q, Herbert KE and Lunec J. Discrepancies in the measurement of UVC-induced 8-oxo-2′-deoxyguanosine: implications for the analysis of oxidative DNA damage. Biochemistry and Biophysics Research Communications 1999; 259: 374.
9. Fischbein A, Sharma OK, Selikoff IJ and Borek E. Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Cancer Research 1983; 43: 2971.
10. Frenkel K, Karkoszka J, Glassman T, Dubin N, Toniolo P, Mooney LA and Kato I. Serum autoantibodies recognizing 5-hydroxymethyl-2′-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. Cancer Epidemiology, Biomarkers and Prevention 1998; 7: 49.
11. Inagaki S, Esaka Y, Sako M and Goto M. Analysis of DNA adducts bases by capillary electrophoresis with amperometric detection. Electrophoresis 2001; 22: 3408.
12. Itoh K, Aida S, Ishiwata S, Yamaguchi T, Ishida N and Mizugaki M. Immunochemical detection of urinary 5-methyl-2′-deoxycytidine as a potential biologic marker for leukemia. Clinica Chimica Acta 1995; 234: 37.
13. Itoh K, Konno T, Sasaki T, Ishiwata S, Ishida N and Misugaki M. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma. Clinica Chimica Acta 1992; 206: 181.
14. Lee SH, Jung BH, Kim SY and Chung BC. A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/ mass spectrometry with direct urine injection. Rapid Communications in Mass. Spectrometry 2004; 18: 973.
15. Li D, Zhang W, Zhu J, Chang P, Sahin A, Singletary E, Bondy M, Hazra T, Mitra S, Lau SS, Shen J and DiGiovanni J, Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Molecular Carcinogens 2001; 31: 214.
16. Matsui A, Iketa T, Enomoto K, Hosoda K, Nakasima H, Omae K, Watanabe M, Hibi T and Kitajima M. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Letters 2000; 151: 87.
17. Nakano K, Nakao T, Schram KH, Hammargren WM, McClure TD, Katz M and Petersen E. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Clinica Chimica Acta 1993; 218: 169.
18. O'Donoghue K, Brown TA, Carter JF and Evershed RP. Application of high performance liquid chromatography/mass spectrometry with electrospray ionization to the detection of DNA nucleosides in ancient seeds. Rapid Communications in Mass Spectrometry 1996; 10: 495.
19. Paleček E. Determination of pseudouridine at submicromolar concentrations by cathodic stripping voltammetry at a mercury electrode. Clinica Chimica Acta 1985; 174: 103.
20. Pouget JP, Douki T, Richard MJ and Cadet J. DNA damage induced in cells by γ and UVA radiation as measured by HPLC/GC-MS and HPLC-EC and comet assay. Chemical Research and Toxicology 2000; 13: 541.
21. Ravanat JL, Guicherd P, Tuce Z and Cadet J. Simultaneous determination of five oxidative DNA lesions in human urine. Chemical Research and Toxicology 1999; 12: 802.
22. Speer J, Gehrke CW, Kwo KC, Waalkes TP and Borek E. tRNA breakdown products as markers for cancer. Cancer 1979; 44: 2120.
23. Topp H, Duden R and Schöch G. 5,6-Dihydrouridine: a marker ribonucleoside for determining whole body degradation rates of transfer RNA in man and rats. Clinica Chimica Acta 1993; 218: 73.
24. Thomale J and Nass G. Increasing urinary levels of modified nucleosides and bases during tumor development in mice. Recent Results in Cancer Research 1983; 84: 377.
25. Zambonin CG, Aresta A, Palmisano F, Specchia G and Liso V. Liquid chromatographic determination of urinary 5-methyl-2′-deoxycytidine and pseudouridine as potential biological markers for leukaemia. Journal of Pharmaceutical and Biomedical Analysis 1999; 21: 1045.